Texas 2023 - 88th Regular

Texas Senate Bill SB309

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to COVID-19 prevention and treatment information provided to individuals receiving a COVID-19 viral test.

Impact

This legislation will amend the Health and Safety Code, particularly by introducing a new subchapter focused on COVID-19. By requiring health care providers to provide essential information at the point of testing, SB309 aims to bridge the gap in communication that has been prominent during the pandemic. This effort may lead to better health outcomes by encouraging patients to seek timely treatment and consider preventive health practices, such as vaccination and the use of therapeutics.

Summary

SB309 aims to enhance the information available to individuals undergoing COVID-19 testing by mandating health care providers to distribute a brochure that outlines prevention and treatment options. The bill specifically directs the Department of State Health Services to create and post this brochure online, ensuring accessibility to critical information related to COVID-19. By emphasizing the importance of both preventative measures and immediate treatment, the bill seeks to improve community awareness and responses towards the virus, especially in making informed decisions regarding vaccination and treatment options.

Sentiment

The sentiment surrounding SB309 appears to be positive among supporters who view it as a proactive measure to combat COVID-19. Many legislators express approval of the bill as they believe it empowers individuals with necessary information to make better health decisions. However, there are concerns regarding the effectiveness and reliability of the information being disseminated, particularly in terms of what sources are being cited and how well the guidelines align with current medical advice.

Contention

Despite the bill's favorable reception in some quarters, notable points of contention may arise around the content of the brochure and the role of health care providers in ensuring patients understand the information provided. Some critics may argue that the bill does not sufficiently address misinformation surrounding COVID-19 treatment and prevention, questioning whether standardization of the information is enough to combat varied public perceptions and misconceptions about the virus and its treatments. Additionally, the definition of acceptable treatments and methods for improving immune function may also be points of debate.

Companion Bills

No companion bills found.

Previously Filed As

TX HB943

Relating to informed consent before the provision of certain medical treatments involving COVID-19 vaccination.

TX SB883

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

TX HB20

Relating to informed consent before provision of certain medical treatments and exemptions from COVID-19 vaccination requirements.

TX HB540

AN ACT relating to coverage for COVID-19 testing.

TX A545

Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.

TX HB2157

Expanding pharmacist's scope of practice to include point-of-care testing for and treatment of COVID-19.

TX SB2422

Relating to investigations and disciplinary or punitive action by the Texas Medical Board regarding certain treatments or practices regarding COVID-19 and to the required expungement of certain records.

TX HB1792

SCH CHILDREN-COVID-19 VACCINE

TX SB222

Prohibits educational institutions from mandating COVID-19 vaccines or gene therapy treatments

TX SB1428

Prohibits educational institutions from mandating COVID-19 vaccines or gene therapy treatments

Similar Bills

No similar bills found.